Two weeks after the judge in charge of nearly 8,000 suits over the acne medication Accutane spurned Hoffmann-La Roche’s attempt to remove her, the drug maker is escalating its efforts.
On Monday, Roche filed a motion for leave to appeal Superior Court Judge Carol Higbee’s Feb. 13 rejection of the argument that she harbors a pro-plaintiff bias that requires her recusal.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
